NFKB1 and Insulin resistance: The recent findings on FGF-21 ability to prevent insulin resistance in human myoblasts by inhibiting NF-κB activation [51] may also suggest that the muscle-derived FGF-21 acts in an autocrine fashion to amplify PPAR-δ inhibitory effects on the expression of NF-κB-dependent inflammatory genes.